Mia's Feed
Medical News & Research

Study Reveals Severe Economic Impact of Chronic Lung Disease in Kenya

Study Reveals Severe Economic Impact of Chronic Lung Disease in Kenya

Share this article

A new study reveals that over a quarter of adults with symptoms of chronic lung disease in Kenya face catastrophic health costs, emphasizing the need for improved health insurance coverage.

2 min read

Recent research published in The Lancet Global Health highlights the significant financial burden faced by individuals in Kenya exhibiting symptoms of chronic respiratory diseases, including conditions like asthma and COPD. The study, conducted across five health facilities in Meru County, examined nearly 300 adults seeking treatment and found that approximately 26% experienced 'catastrophic health expenditure' (CHE). CHE is defined as healthcare-related costs exceeding 10% of their household’s monthly income, which can lead to severe financial hardship.

This economic strain encompasses direct medical expenses such as consultations, diagnostic tests, medicines, and treatments, as well as indirect costs like transportation for patients and accompanying caregivers. Notably, most participants were not members of Kenya’s national insurance scheme, which is currently undergoing reforms, and even those enrolled often did not utilize it for their care.

The study revealed that women, individuals from lower socioeconomic backgrounds, and patients seeking treatment at better-equipped, distant hospitals bore the heaviest financial burdens. It was observed that nearly all participants resorted to coping strategies such as borrowing money, selling household assets, or depleting savings to manage expenses.

Led by the Liverpool School of Tropical Medicine and the Kenya Medical Research Institute, the study underscores the urgent need for improved health financing models. Dr. Tom Wingfield emphasized that the financial burden linked to chronic respiratory ailments is substantial, especially for vulnerable populations, and that expanding and effectively implementing social health insurance could mitigate these costs.

Chronic respiratory diseases are among the top non-communicable diseases contributing to global premature deaths. Addressing the financial challenges and enhancing primary healthcare access aligns with the United Nations’ goal to reduce NCD-related deaths by 30% by 2030. Strengthening health systems to provide affordable and comprehensive coverage remains crucial for reducing out-of-pocket expenses and preventing medical impoverishment in Kenya.

For more details, see the full study: Stephen Mulupi et al., Catastrophic health expenditure, social protection coverage, and financial coping strategies in adults with symptoms of chronic respiratory diseases in Kenya, published in The Lancet Global Health.

source: https://medicalxpress.com/news/2025-06-people-symptoms-chronic-lung-disease.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Uncertainty Surrounds the Safety and Effectiveness of Popular Air Cleaning Devices

Most portable air cleaning devices are rarely tested on people, leaving uncertainties about their effectiveness and potential health harms. A recent review emphasizes the need for thorough real-world testing to ensure safety and efficacy.

Uncovering the Key Mechanism Behind High Blood Pressure

A new study uncovers the role of the enzyme JMJD3 in regulating blood vessel function and its impact on hypertension, offering potential for targeted personalized therapies.

Persistent Sexual Health Gaps Among Migrant Youth in Canada Highlight Systemic Barriers

A new study reveals ongoing sexual health disparities among migrant youth in Canada, highlighting systemic barriers such as education gaps and access issues, despite lower sexual activity rates.

Inflammation and Nutrition Scores as Prognostic Indicators in Low-Risk Myelodysplastic Syndrome

New research identifies inflammation and nutritional scores as key prognostic indicators in low-risk myelodysplastic syndrome, potentially guiding future treatment strategies.